Dizlin Pharmaceuticals Ab Is A Privately Held Swedish Research Based Pharmaceutical Development Company With Focus On Diseases Of The Central Nervous System In General And On Developing Improved Treatment For Advanced Stages Of Parkinson S Disease In Particularthe Company Conducts Research In Collaboration With Researchers At The University Of Gothenburg And Linka Ping University In Sweden The Company Has Developed A New Patented Method For Treatment Of Advanced Stages Of Parkinson S Diseasedizlin Pharmaceuticals Has Two Products In Late Phase Development Stagethe First Infudopa Intrava C Aeis Administered Intravenously To Minimize Risks Associated With Surgery On Patients With Parkinson S Diseasethe Second Aeinfudopa Subca C Aeis Administered As A Continuous Subcutaneous Infusion By Means Of A Portable Pumpsimilar To Insulin Infusion For Diabetes
